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Background: Adiponectin, paradoxically reduced in obesity and with lower levels in African Americans (AA),
modulates several cardiometabolic risk factors. Because abdominal visceral adipose tissue (VAT), known to be
reduced in AA, and subcutaneous adipose tissue (SAT) compartments may confer differential metabolic risk profiles,
we investigated the associations of VAT and SAT with serum adiponectin, separately by gender, with the hypothesis
that VAT is more strongly inversely associated with adiponectin than SAT.
Methods: Participants from the Jackson Heart Study, an ongoing cohort of AA (n = 2,799; 64% women; mean age,
55 ± 11 years) underwent computer tomography assessment of SAT and VAT volumes, and had stored serum
specimens analyzed for adiponectin levels. These levels were examined by gender in relation to increments of VAT
and SAT.
Results: Compared to women, men had significantly lower mean levels of adiponectin (3.9 ± 3.0 μg/mL vs.
6.0 ± 4.4 μg/mL; p < 0.01) and mean volume of SAT (1,721 ± 803 cm3 vs. 2,668 ± 968 cm3; p < 0.01) but significantly
higher mean volume of VAT (884 ± 416 cm3 vs. 801 ± 363 cm3; p < 0.01). Among women, a one standard deviation
increment in VAT was inversely associated with adiponectin (β = − 0.13; p < 0.0001) after controlling for age, systolic
blood pressure, fasting plasma glucose, high-density lipoprotein cholesterol, triglycerides, education, pack-years of
smoking and daily intake of alcohol. The statistically significant inverse association of VAT and adiponectin persisted
after additionally adjusting for SAT, body mass index (BMI) and waist circumference (WC), suggesting that VAT
provides significant information above and beyond BMI and WC. Among men, after the same multivariable
adjustment, there was a direct association of SAT and adiponectin (β = 0.18; p = 0.002) that persisted when
controlling for BMI and WC, supporting a beneficial effect of SAT. Insulin resistance mediated the association of SAT
with adiponectin in women.
Conclusion: In African Americans, abdominal visceral adipose tissue had an inverse association with serum
adiponectin concentrations only among women. Abdominal subcutaneous adipose tissue appeared as a protective
fat depot in men.* Correspondence: abidulescu@msm.edu
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Obese individuals, particularly those with accumulated
visceral fat, have reduced plasma levels of adiponectin
[1], and are at increased risk for hypertension, type 2
diabetes and atherosclerotic events [2,3]. Adiponectin
has been suggested to play an important role in athero-
sclerosis, endothelial inflammation, myocardial remod-
eling and several of the cardiometabolic risk factors [4,5].
Few studies have investigated the association of adiponectin
with obesity (especially different fat deposits) in African
Americans, known to have a lower plasma level of this
adipokine [6-8].
Fat compartments have been shown to be differen-
tially associated with the metabolic risk [9]. Variations
in fat distribution mediate cardiometabolic risk factors
[10]. Recent studies have shown that visceral adipose
tissue (VAT) is more strongly associated with an adverse
metabolic risk profile than subcutaneous adipose tissue
(SAT) in both whites and African Americans [9-11]. We
recently showed in the Jackson Heart Study (JHS) co-
hort of African Americans that VAT is a stronger correl-
ate than SAT for most cardiometabolic risk factors, and
that it remains significantly associated with these factors
even after accounting for body mass index (BMI) [12].
Among obese Caucasians Framingham Heart Study (FHS)
participants, SAT was a fat depot protective against high
triglycerides levels [13].
The present study was designed to examine the as-
sociations of abdominal adiposity compartments with
adiponectin in a large community-based sample of African
Americans. The scientific hypothesis was that, similarly
with white populations, VAT is more strongly inversely
associated with serum adiponectin than is SAT. We aimed
to determine if volumetric imaging methods of SAT and
VAT provide information about adiponectin beyond that
offered by simpler measures such as BMI and waist circum-
ference (WC). We also queried if these associations are
dependent on gender and if insulin resistance mediates the
association of abdominal adipose tissues with adiponectin.
Methods
Study population
The JHS is a single-site, prospective cohort study of the
risk factors and causes of heart disease in adult African
Americans. A probability sample of 5,301 AA, aged 21 –
94 years, residing in a three county area surrounding
the city of Jackson, MS, was recruited and examined at
baseline (2000–2004) by certified technicians according
to standardized protocols. Clinic visits and interviews
occur approximately every three years. Annual follow-up
interviews and cohort surveillance are ongoing. An over-
view of the JHS [14] and details of the study design and
data collection methods [15] are published elsewhere. The
present study included 2,799 participants who underwentmulti-detector computed tomography (CT) measurements
for visceral adiposity between 2007 and 2009 as part of the
second JHS examination (JHS Exam 2) and had plasma
adiponectin measured using frozen specimens stored
at JHS Exam 1 (2000 – 2004). Written consent was ob-
tained from each participant at the inception of the
study, and the study protocol was approved by the Insti-
tutional Review Boards of the Morehouse School of
Medicine and the participating JHS institutions: Jackson
State University, Tougaloo College and the University of
Mississippi Medical Center.
Multi-detector CT scanning protocol for measuring
adiposity
Overall, 4,203 participants attended the JHS Exam 2. Of
these, 2,884 underwent multi-detector CT assessment for
abdominal VAT and SAT. Participants were excluded from
the CT scan exam if: 1) body weight was greater than 350
pounds (~160 kg) due to scanner limits; 2) pregnant or un-
known pregnancy status; 3) female participants < 40 years
of age; 4) male participant < 35 years of age. The research
CT protocol included the heart and lower abdomen using
a 16 channel multi-detector computed tomography system
equipped with cardiac gating (GE Healthcare Lightspeed
16 Pro, Milwaukee, Wisconsin). Quality control and image
analysis was performed at a core reading center (Wake
Forest University School of Medicine, Winston-Salem,
NC). The protocol included scout images, one ECG gated
series of the entire heart, 110 and a series through the
lower abdomen. The acquired abdominal imaging slices
covering the lower abdomen from L3 to S1 were used for
assessing VAT and SAT. Briefly, 24 contiguous 2-mm thick
slices centered on the lumbar disk space at L4-5 were used
for this analysis; 12 images before the center of the L4 - L5
disk space and 12 images after the disk space were used for
quantification of VAT and SAT. The abdominal muscular
wall was firstly manually traced and the fat volumes in dif-
ferent compartments were measured by semiautomatic seg-
mentation technique. Secondly, Volume Analysis software
(Advantage Windows, GE Healthcare, Waukesha, WI) was
used to segment and characterize each individual voxel as
a tissue attenuation of fat using a threshold range −190
to −30 Hounsfield units. The VAT and SAT volumes were
the sum of VAT and SAT voxel over 24 slices. In our previ-
ous study, in a random selected sample of 60 participants,
we found an interclass correlation coefficient for inter-
reader comparisons of 0.95 for both VATand SAT [12].
Covariates
Covariate information was ascertained during the JHS
Exam 1 (2000–2004). In all participants, the clinic visit
included physical examination, anthropometry, survey of
medical history and current medication use and collection
of blood and urine specimens for biological assessment. In-
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weight examination clothing without shoes or constricting
garments. We calculated body mass index (BMI) as weight
in kilograms divided by height in meters squared (kg/m2).
Waist circumference (WC) was measured at the level of
the umbilicus using a non-elastic tape measurer and roun-
ded to the nearest centimeter. Education (as a measure of
socioeconomic status) was categorized into four categories;
less than high school (HS), HS graduate, more than HS but
less than college and college graduate or more. Pack-years
of smoking (defined as the number of years of smoking
times the average number of cigarettes smoked per day
divided by 20) were used as a variable in the multivariable
models. Alcohol drinking (grams/day), also used in the
multivariable modeling, was estimated from the frequency
and portion sizes of beer, wine, and liquor ascertained from
a validated 158-item food frequency questionnaire [16].
Menopausal status was queried through a self-reported
questionnaire.
Lipid variables (high-density lipoprotein cholesterol,
HDL-C and triglycerides, TG), fasting plasma glucose
(FPG) and fasting insulin (FI) were measured using
standard laboratory techniques. Insulin resistance status
was estimated with the homeostasis model assessment,
HOMA-IR, as (FPG x FI)/22.5 [17].
Adiponectin measurement
Venous blood samples were withdrawn from each subject
at baseline examination after more than 8 hours of fasting
as described elsewhere [15]. Vials of serum were stored at
the JHS central repository in Minneapolis, MN, at −80°C
until assayed. Adiponectin concentration was measured in
2008 – 2012 as total adiponectin by an ELISA system
(R&D Systems; Minneapolis, MN) [18]. The inter-assay
coefficient of variation was 8.8%. No biological degrad-
ation has been described using stored specimens, indicat-
ing a high validity for our measurements [19].
Statistical analysis
All analyses were stratified by gender to explore hetero-
geneities in the independent associations of adiponectin
with the adiposity compartments. Both adiposity measures
(VAT and SAT) were standardized by dividing them to
their population standard deviation. Thus, all the regres-
sion coefficients were expressed per one standard deviation
increase in VAT or SAT. Two-way interactions between
adiposity measures and gender were formally tested by
adding interaction terms in the fully multivariable adjusted
models.
VAT and SAT were normally distributed; adiponectin
values were positively skewed and normalized by loga-
rithmic transformation (base 10). Age-adjusted Pearson
correlations of VAT and SAT with adiponectin, the
metabolic risk factors (systolic blood pressure, fastingplasma glucose, triglycerides, high-density lipoprotein
(HDL) cholesterol, HOMA-IR), smoking and alcohol in-
take were performed. Multivariable regression models
were constructed with VAT or SAT as the main independ-
ent variables (in separate and concomitant models) and
adiponectin as the dependent variable. Models were
generated in sequence by adding BMI, WC or both to the
basic multivariable model that included age, systolic blood
pressure, fasting plasma glucose, HDL-cholesterol, trigly-
cerides, education, smoking and alcohol consumption. In
order to contrast the added value of VAT and SAT above
and beyond those of BMI and WC, we calculated and
contrasted the models’ R-square, as explained variance. We
also estimated the main variables associated with adipo-
nectin (principal contributors to its variance) by using step-
wise linear regression models in which HOMA-IR was
added to the previous group of variables. The significance
level cutpoint considered for entry into the stepwise
forward-selection model was lower than 0.50. In order to
assess the effect of weight change between the visits, we
performed additional analyses with exclusion of partici-
pants that had more than one and a half BMI units change
(which correspond to a 5 kg change in weight in a person
1.8 meters tall). We additionally conducted sensitivity
analyses by excluding the participants on cardiovas-
cular and lipid lowering medications, namely beta-
blockers, angiotensin-converting-enzyme inhibitors,
calcium-channels blockers and statins. All computations
were performed by SAS software version 9.2 (SAS Institute
Inc., Cary, North Carolina).
Results
The study sample was comprised of 1,801 women (64%)
and 998 men. The characteristics of the participants ac-
cording to gender are presented in Table 1. The mean
(standard deviation) age of the study sample was 55 (11)
years for women and 54 (11) for men; it was 55 (11) years
for the entire sample and thus similar with the entire JHS
cohort [55 (13) years]. Men had significantly lower mean
levels of adiponectin (3.9 μg/mL) than women (6.0 μg/mL;
p < 0.0001). Men had significantly higher mean volumes
of VAT as compared to women (884 cm3 vs. 801 cm3; p <
0.0001), whereas women had higher SAT volumes com-
pared to men (2,668 cm3 vs. 1,721 cm3; p < 0.0001 for
difference, Table 1). Statistically significant differences by
gender were observed for the majority of the study
covariates (including BMI). The distributions of fasting
plasma glucose, systolic blood pressure and education did
not differ by gender (Table 1).
Correlations between obesity measures and adiponectin
and other variables
Age-adjusted correlates of VAT and SAT with adiponectin
and other covariates considered in our study are presented
Table 1 Characteristics (mean ± standard deviation) of
study participants (N = 2,799)
Women (N = 1,801) Men (N = 998) P-value
Age (years) 55 ± 11 54 ± 11 .0004
Adiponectin (μg/mL) 6.0 ± 4.4 3.9 ± 3.0 < .0001
VAT (cm3) 801 ± 363 884 ± 416 < .0001
SAT (cm3) 2,668 ± 968 1,721 ± 803 < .0001
BMI (kg/m2) 32.5 ± 6.8 29.4 ± 5.1 < .0001
WC (cm) 99.6 ± 16.1 100.3 ± 12.8 < .0001a
TG (mg/dL) 100.8 ± 65.2 109.9 ± 66.9 .0007
HDL-C (mg/dL) 55.3 ± 14.8 45.7 ± 11.7 < .0001
FPG (mg/dL) 97.3 ± 28.0 98.2 ± 26.7 .47
HOMA-IR 3.7 ± 2.3 3.3 ± 2.5 .0002
SBP (mm Hg) 125.7 ± 17.2 126.4 ± 16.6 .25
Education (≥ college) 38.7 37.3 .11
Smoking 4.3 ± 11.7 10.0 ± 19.3 < .0001
Alcohol intake 1.4 ± 5.7 8.8 ± 27.7 < .0001
aWhen compared as categorical variables defined with the US National
Cholesterol Education Program Adult Treatment Panel III cutpoints criteria for
abdominal obesity (88 cm in women and 102 cm in men);
VAT: visceral adipose tissue; SAT: subcutaneous adipose tissue; BMI: body mass
index; WC: waist circumference; FPG: fasting plasma glucose in mg/dL; HOMA-
IR: homeostasis assessment model - insulin resistance; SBP: systolic blood
pressure in millimeters of mercury; TG: triglycerides in mg/dL; HDL-C: high-
density lipoprotein-cholesterol in mg/dL; education: college education
graduate or more (in percentage); smoking in packs-year and alcohol intake
in grams/day.
Bidulescu et al. BMC Cardiovascular Disorders 2013, 13:9 Page 4 of 10
http://www.biomedcentral.com/1471-2261/13/9in Table 2. The correlation of adiponectin with abdominal
adiposity measures was higher for VAT and higher for
both VAT and SAT in women compared with men. In
both genders, BMI and WC were correlated more strongly
with SAT than VAT. HDL-cholesterol, triglycerides andTable 2 Age-adjusted Pearson correlation coefficients betwee
Women (N = 1,801)
Adiponectin VAT SAT BMI
Adiponectin —
VAT - 0.31c —
SAT - 0.16c 0.46c —
BMI - 0.24c 0.50c 0.78c —
WC - 0.33c 0.57c 0.73c 0.81c
Smoking - 0.003 0.04 - 0.04 - 0.04
Alcohol intake 0.03 - 0.002 - 0.08b - 0.08b -
TG - 0.27c 0.21c - 0.003 0.09c
HDL-C 0.41c - 0.21c - 0.09c - 0.19c -
FPG - 0.28c 0.23c 0.17c 0.22c
HOMA-IR - 0.42c 0.38c 0.24c 0.35c
SBP - 0.01 0.04 0.05 0.12c
ap < 0.05; bp < 0.01; cp < 0.001;
VAT: visceral adiposity tissue area; SAT: subcutaneous adipose tissue area; BMI: bod
transformed adiponectin plasma levels; p: p-values; HDL-C: high density lipoprotein
model - insulin resistance; SBP: systolic blood pressure.fasting plasma glucose levels correlated more highly with
VAT than with SAT, especially in women. The blood pres-
sure values had low correlations with both VAT and SAT.
BMI and WC had moderate correlations with the majority
of cardiometabolic risk factors (Table 2).
Multivariable-adjusted regression models of adiponectin
on VAT or SAT
Gender proved to be an effect modifier of both the asso-
ciation between serum adiponectin and VAT (p for
interaction = 0.003) as well as for the association be-
tween adiponectin and SAT (p for interaction = 0.001).
The results of the multiple linear regression analyses for
the gender-specific association of VAT or SAT with log-
transformed adiponectin are presented in Table 3. In
women, a one standard deviation increment in either
VAT or SAT was inversely associated with adiponectin
(β = − 0.13 for VAT and β = − 0.07 for SAT) after con-
trolling for age, systolic blood pressure, fasting plasma
glucose, triglycerides, HDL-cholesterol, education, pack-
years of smoking and daily intake of alcohol when these
two adiposity measures were included separately in the
models (models 1 and 2, respectively). The significant
inverse association of VAT and adiponectin persisted
after additionally adjusting for SAT, BMI or/and WC
(model 3, 4, 5 and 6, respectively). The association of
adiponectin with SAT became nonsignificant after ac-
counting for BMI (model 7). Among our women par-
ticipants, same results were obtained when adjusting
additionally for menopausal status. Specifically, in the fully
adjusted model that included BMI and WC (the equiva-
lent of model 6), the inverse association between
adiponectin and VAT was the same: β = − 0.08, p < 0.0001.n adiponectin, VAT, SAT and covariates (N = 2,799)
Men (N = 998)
WC Adiponectin VAT SAT BMI WC
—
- 0.17c —
- 0.10b 0.50c —
- 0.21c 0.49c 0.74c —
— - 0.20c 0.58c 0.82c 0.84c —
- 0.01 0.02 0.06 - 0.07 - 0.09a - 0.05
0.06a 0.09a 0.03 - 0.08a - 0.09b - 0.05
0.16c - 0.27c 0.30c 0.13c 0.20c 0.23c
0.23c 0.36c - 0.24c - 0.23c - 0.32c - 0.33c
0.26c - 0.14c 0.23c 0.15c 0.21c 0.26c
0.41c - 0.28c 0.30c 0.28c 0.34c 0.40c
0.08b - 0.01 0.16b 0.05 0.13b 0.09a
y mass index; WC: waist circumference; Adiponectin: logarithmically-
cholesterol; FPG: fasting plasma glucose; HOMA-IR: homeostasis assessment
Table 3 Multivariable-adjusted regression coefficients of VAT and SAT with adiponectin levels a by gender (N = 2,799)
Models Covariates VAT β Coefficient P-value Model’s R-square SAT β Coefficient P-value Model’s R-square
Women (N = 1,801)
Model 1 Basicb + VAT - 0.13 < .0001 0.24 — — —
Model 2 Basic + SAT — — — - 0.07 < .0001 0.22
Model 3 Basic + VAT, SAT - 0.13 < .0001 0.23 - 0.02 .32 0.24
Model 4 Basic + VAT, BMI - 0.11 < .0001 0.24 — — —
Model 5 Basic + VAT, WC - 0.08 < .0001 0.25 — — —
Model 6 Basic + VAT, BMI, WC - 0.08 < .0001 0.26 — — —
Model 7 Basic + SAT, BMI — — — - 0.001 .97 0.22
Model 8 Basic + SAT, WC — — — 0.06 .01 0.25
Model 9 Basic + SAT, BMI, WC — — — 0.05 .05 0.25
Men (N = 998)
Model 1 Basicb + VAT - 0.03 .12 0.16 — — —
Model 2 Basic + SAT — — — 0.03 .27 0.17
Model 3 Basic + VAT, SAT - 0.05 .02 0.17 0.06 .05 0.17
Model 4 Basic + VAT, BMI - 0.02 .29 0.17 — — —
Model 5 Basic + VAT, WC - 0.03 .24 0.17 — — —
Model 6 Basic + VAT, BMI, WC - 0.03 .24 0.17 — — —
Model 7 Basic + SAT, BMI — — — 0.18 .002 0.17
Model 8 Basic + SAT, WC — — — 0.16 .001 0.18
Model 9 Basic + SAT, BMI, WC — — — 0.18 .0002 0.18
aLog-transformed values;
bBasic multivariable model: covariates used for adjustment were age, systolic blood pressure, fasting plasma glucose, HDL-cholesterol, triglycerides, education (in
four categories as described), smoking (pack-years) and alcohol intake (grams/day);
BMI: body mass index; WC: waist circumference; VAT: visceral adiposity tissue area; SAT: subcutaneous adipose tissue area.
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adiponectin (β = 0.18, 0.16 and 0.18; p = 0.002 to 0.0002)
that was revealed when adjusting for BMI or/and WC
(models 7, 8 and 9 in Table 3).
Similar results with those presented in Tables 2 and 3
were obtained in the additional analyses with exclusion of
participants with more than one and a half BMI units
change between visits (N = 1,525). Specifically, among
women, a one standard deviation increment in VAT was in-
versely associated with adiponectin (β = − 0.12, p < 0.0001)
after multivariable adjustment that included BMI and WC
(the equivalent model 6 from Table 3). Among men, a one
standard deviation increment in SAT was directly asso-
ciated with adiponectin (β = 0.08, p = 0.04) after multi-
variable adjustment that included also BMI and WC (the
equivalent model 9 from Table 3).
Also, similar results were obtained when excluding
participants on medications such as beta-blockers,
angiotensin-converting-enzyme inhibitors, calcium-
channels blockers and statins (N = 2,113). Specifically,
among women, a one standard deviation increment in
VAT was inversely associated with adiponectin (β = − 0.08,
p = 0.0001) after multivariable adjustment that includedBMI and WC (the equivalent model 6 from Table 3).
Among men, a one standard deviation increment in
SAT was directly associated with adiponectin (β = 0.17,
p = 0.002) after the same multivariable adjustment (the
equivalent model 9 from Table 3).
Table 4 presents the main variables associated with
adiponectin levels according to gender, as indicated by the
stepwise regression procedure using a glucose metabolism-
related stage-modeling strategy. Insulin resistance showed
minimal effect on the association of adiponectin with ab-
dominal adiposity compartments. HOMA-IR mediated
however the association of adiponectin with SAT among
women. The main variance contributors for adiponectin
were HDL-cholesterol and insulin resistance, in this order,
in both genders (results not shown).Differential association of VAT and SAT with adiponectin
In both genders, within the lowest VAT tertile, there was a
statistically significant increase in adiponectin levels from
the lowest to the highest SAT tertile (Figures 1 and 2). No
such increase was documented within the highest two
VAT tertiles.
Table 4 Stepwise regression stage-models of adiponectina with glucose metabolism components by genderb
(N = 2,799)
Model without FPGc or IRc Model with FPG Model with IR
Independent Variable Estimate (β coefficient) P-value Estimate (β coefficient) P-value Estimate (β coefficient) P-value
Women (N = 1,801)
VAT - 0.09 < .0001 - 0.08 < .0001 - 0.07 .0002
SAT 0.06 .02 0.06 .02 0.04 .09
Age 0.01 < .0001 0.01 < .0001 0.01 < .0001
BMI 0.005 .23 0.005 .22 0.01 .09
WC - 0.01 < .0001 - 0.01 < .0001 - 0.01 < .0001
SBP 0.001 .29 0.001 .27 0.001 .12
HDL-C 0.01 < .0001 0.01 < .0001 0.01 < .0001
TG - 0.001 < .0001 - 0.001 < .0001 - 0.001 .05
Smoking — — — — — —
Alcohol Intake — — — — — —
FPG N/Ad N/Ad - 0.0004 .43 N/Ad N/Ad
HOMA-IR N/Ad N/Ad N/Ad N/Ad - 0.06 < .0001
Men (N = 998)
VAT - 0.03 .21 - 0.03 .21 - 0.03 .30
SAT 0.18 .0002 0.18 .0002 0.13 .004
Age 0.01 .0001 0.01 <.0001 0.01 .001
BMI - 0.01 .008 - 0.01 .10 - 0.02 .01
WC - 0.01 .12 - 0.01 .14 — —
SBP 0.001 .26 0.002 .24 0.001 .37
HDL-C 0.01 < .0001 0.01 <.0001 0.01 < .0001
TG - 0.001 .002 - 0.001 .002 - 0.001 .01
Smoking 0.001 .33 0.001 .28 — —
Alcohol Intake 0.001 .11 0.001 .12 0.001 .11
FPG N/Ad N/Ad - 0.001 .20 N/Ad N/Ad
HOMA-IR N/Ad N/Ad N/Ad N/Ad - 0.05 < .0001
aLog-transformed values;
bP-value for sex by VAT interaction was 0.001 in the first model (without IR), 0.004 in the second model (with FPG), and 0.003 in the third model (with IR);
cBy fasting plasma glucose (FPG) and/or HOMA-IR as continuous variables;
dN/A: not applicable (not used within the model);
The significance level considered for entry into the stepwise forward-selection regression model was 0.50.
BMI: body mass index; WC: waist circumference; VAT: visceral adiposity tissue; SAT: subcutaneous adipose tissue; SBP: systolic blood pressure; HOMA-IR:
homeostasis assessment model - insulin resistance; HDL-C: high density lipoprotein-cholesterol; TG: triglycerides; smoking in packs-year and alcohol intake
in grams/day.
Model’s R-square for the full model (without FPG or HOMA-IR): 0.29 in women and 0.18 in men; for the full model (with FPG): 0.26 in women and 0.18 in men; for
the full model (with HOMA-IR): 0.32 in women and 0.21 in men.
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Principal findings
Our study carried out in a large population-based sam-
ple of African Americans showed that volumetric CT-
scan measures of VAT and SAT were associated with
adiponectin depending on gender. In women, the signifi-
cant inverse association of VAT and adiponectin per-
sisted after additionally adjusting for body mass index
(BMI) and waist circumference (WC), suggesting that
VAT provides significant information above and beyond
BMI. Moreover, the significant inverse association withadiponectin persisted after including SAT into the
model. In men, SAT had a significant direct association
with adiponectin that persisted after including BMI and
WC to the model. In both genders, in the lowest VAT
tertile, there was an increase in adiponectin levels from
the lowest to the highest SAT tertile. It is notable that,
in contrast to African American women, VAT was not
a significant predictor of adiponectin levels in African
American men. Our study confirms insulin resistance as
a mediator for the association of adiponectin with sub-
cutaneous abdominal adiposity compartment in women.
Figure 1 Mean adiponectin levels in JHS women participants partitioned by tertiles of VAT and tertiles of SAT. Subgroup sizes for each
SAT tertile within VAT tertile were 200, 201 and 200 from the lowest to the highest. Error bars represent standard errors. P-values are given for
linear trend in means of adiponectin levels.
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Our results are consistent with the observation that men
are prone to abdominal fat deposition, particularly in the
abdominal cavity, a condition described as visceral obesity
[20]. Notably, despite known differences in body fat distri-
bution between individuals of African and European ances-
try [21,22], we found similar gender interactions with VAT
and adiponectin levels as in previous studies [8]. Similarly,
gender proved to be an effect modifier of the association
between SAT and serum adiponectin [23]. Nevertheless,
opposite to previous studies that indicated an inverse asso-
ciation between SAT and adiponectin [23], our investi-
gation suggested a direct association between these two
variables, confirming a series of previous investigations
[24,25]. Among men, the nonsignificant association be-
tween VAT and adiponectin provides insight which might
explain why when compared with other races/ethnicities
African American men have lower adiponectin levels des-
pite smaller VATcompartments.
Waist circumference cannot differentiate between VAT
and SAT compartments despite the fact that WC appears
as a good predictor of VAT [26]. This is particularly im-
portant, as VAT and SAT may be differently associated
with inflammatory cytokines secretion and with differential
metabolic risk profiles [27]. The negative correlation be-
tween adiponectin and VAT is stronger than with SATFigure 2 Mean adiponectin levels in JHS men participants partitioned
tertile within VAT tertile were 111, 111 and 110 from the lowest to the high
trend in means of adiponectin levels.[28,29]. In 69 non-diabetic African Americans, adiponectin
negatively correlated with VAT (r = −0.41) in men and with
VAT (r = −0.55) and SAT (r = −0.35) in women [8]. In
findings similar to our own, Considine and colleagues
found that SAT was not significantly associated with
adiponectin in the models that adjusted concomitantly for
VAT [8].
Recent Jackson Heart Study (JHS) data suggest that ab-
dominal obesity is particularly profound among African
Americans as indicated by the fact that nearly two-thirds
of the JHS sample has an elevated WC [30]. Whether
compared with whites, African Americans with elevated
WC experience a higher risk for cardiovascular events due
to greater abdominal adiposity is uncertain because whites
have greater VAT than African Americans [31] and, in na-
tionwide samples, higher WC [32]. At similar degrees of
obesity as defined by BMI, African Americans have a
lower quantity of VAT compared with whites and Asian
populations, despite higher rates of insulin resistance, dia-
betes and hypertension [33].
VAT secretes less adiponectin than SAT [34]. Low levels
of adiponectin, high levels of leptin and chronic low-grade
inflammatory state are generally observed in the obese sta-
tus and have been associated with insulin resistance and
metabolic syndrome [2]. Preliminary clinical evidence has
linked these adipose tissue-derived hormones to measuresby tertiles of VAT and tertiles of SAT. Subgroup sizes for each SAT
est. Error bars represent standard errors. P-values are given for linear
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cular events [35], suggesting that adiponectin, leptin and
C-reactive protein (CRP) may play an important role for
increased risk of cardiovascular mortality in individuals
with the metabolic syndrome. In the few studies conduc-
ted so far, higher WC was associated with lower total
adiponectin after controlling for the effect of total fat
mass, indicating that these associations are driven mainly
by central fat accumulation, as indicated by the WC level
rather than by total body adiposity [36,37]. As shown by
Steffes and colleagues in the CARDIA cohort (3,355 study
participants), central obesity, as measured by WC, is a pri-
mary factor affecting levels of circulating adiponectin [38].
Similarly with our investigation, both SAT and VAT were
strongly correlated with insulin resistance (but with gen-
der differences) in an investigation conducted among 78
nondiabetic African Americans [39]. Moreover, as shown
by Tulloch-Reid and colleagues [39], among African
American women SAT have a greater effect on insulin re-
sistance, in agreement with our findings.
Few previous studies have assessed the association of
adiponectin with abdominal adipose tissue compart-
ments as measured by CT scan. In a study conducted in
nondiabetic women, adiponectin was more strongly
determined by VAT, whereas leptin was more strongly
influenced by SAT [23]. In an investigation conducted in a
Japanese male population, adiponectin levels were inversely
associated with VAT and directly associated with SAT when
these two measures of abdominal adiposity were both in a
regression model [25]. In this study from Japan, the nega-
tive regression slope of the association between VAT and
adiponectin (the steepness of the association) was four
times larger compared with that in our African American
population. Considering also the lower VAT volumes (about
75% lower than those in the white participants in the
Framingham Heart Study) and lower adiponectin values in
African Americans compared with white and Asian popu-
lations, this suggests that the VAT – adiponectin relation-
ship is less strong in African Americans men compared
with other populations. In the same direction, in a sample
of participants selected from the IRAS Family Study, sam-
ple that included 522 African-Americans, adiponectin was
significantly associated with age, gender, HDL-cholesterol,
VAT and SAT [24]. The slope of the association between
adiponectin and VAT was more than twice compared with
the value that we detected within our investigation. It is
worthy to note that the mean values of adiponectin within
our sample were lower compared with the IRAS Family
sample as well as with those from the Health ABC study
that reported an association between adiponectin and risk
of coronary heart disease [40]. Our results showing in
women a higher slope of the association between VAT
and adiponectin (when contrasted with that between SAT
and adiponectin) are in agreement with a series humanadiposity tissues studies that indicated a lower adiponectin
secretion in omental fat versus subcutaneous fat [41].
Potential mechanisms
Although traditionally regarded as a silent organ that pas-
sively stores excess energy, the adipose tissue is now
considered an endocrine organ not only contributing to
the management of energy flux within the body but also
interacting with the inflammatory system and the vascular
wall. Several studies have demonstrated that adipose tissue
actively produces a variety of locally and systemically
functioning bioactive molecules that interact in various
obesity-related diseases, e.g., leptin [42], adiponectin [43],
tumor necrosis factor-α (TNF-α) [44], plasminogen-
activator inhibitor type-1 (PAI-1) [45] and resistin [46].
Adiponectin was discovered to be the most abundant
adipose-specific transcript [43]. Furthermore, recent stud-
ies have underlined that there are intricate interplays
among adipocytes, the sympathetic nervous system and
the renin-angiotensin system, which participate in the
obesity-associated dysmetabolic state [47]. The possible
explanation for differences between VAT and SAT may
be related to differences in their anatomic location and
cytokine secretion profiles. SAT may preferentially re-
lease more leptin, whereas VAT may mainly release
tumor-necrosis factor-α, known to influence the secre-
tion of adiponectin [4]. In addition, a series of studies
showed that androgens reduce plasma adiponectin
[48], providing insights into the gender differences of
the association between VAT and adiponectin. Add-
itionally, adiponectin’s compensatory effects of meta-
bolic disorders’ improvements seem to entail massive
expansion of subcutaneous adipose tissue depot [49].
Implications
Despite a lower amount of VAT and a lower concentration
of serum adiponectin in African Americans, the inverse as-
sociation in women of visceral adiposity with adiponectin
that we showed extends the findings from studies among
participants of European ancestry [9,11]. The different
magnitude of the association supports the need for further
studies to assess the mechanisms of this association and to
prospectively link it to cardiometabolic risk. Among men,
the significant direct association of adiponectin with SAT
supports the postulated beneficial effect of SAT (i.e., that
SAT might be a buffer mechanism that acts initially to
compensate for an increase in WC) [13,50].
Strengths and limitations
The main strength of our investigation is that this study is
among the first on the topic with a very large community-
based sample of African Americans. Another strength of
this study is the precise measurement of abdominal VAT
and SAT volumes using advanced imaging techniques.
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adiponectin and visceral adiposity were measured at dif-
ferent points in time. This is partially mitigated by the fact
that similar results were obtained when excluding par-
ticipants with significant body mass change between the
study visits (as our sensitivity-type of analyses indicate).
Another inherent limitation is that generalizability to
other ethnic group cannot be applied.Conclusions
In African Americans, VAT had an inverse association
with serum adiponectin concentrations only among
women. Among men, SAT had a direct association with
adiponectin supporting a buffer mechanisms to com-
pensate for an increase in waist circumference. Consi-
dering the protective role of adiponectin for several
cardiometabolic endpoints, the reduction of visceral fat
in African American women might be an essential pre-
ventive measure for metabolic syndrome and its conse-
quence, cardiovascular disease.
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